soriasis is a chronic inflammatory disease related to many diseases, especially cardiovascular disease. Among these diseases, atherosclerosis plays the most important role. 1 Atherosclerosis is caused by inflammation and an imbalance of the lipid metabolism. Psoriasis and atherosclerosis not only share the same cytokines involved in the immunological mechanism, such as interleukin-17 (IL-17), but also have common angiogenic factors and oxidative pathways. 2 In addition, both of them have similar lipid profiles, including decreased high-density lipoprotein (HDL) levels and/or increased low-density lipoprotein (LDL) levels. 3 In the pathological process of atherosclerosis, the accumulation of cholesterol triggers the production of pro-inflammatory cytokines, such as Tumor Necrosis Factor Alpha (TNF?), and also leads to the aggregation of monocytes and differentiation into foam cells. TNF? eventually induces an inflammatory cascade in blood vessels. 4 In chronic inflammation TNF? may also influence the lipid profile, such as LDL-C levels, via a decreased concentration of a Apolipoproteins. Moreover, TNF? lowers the quality of lipoprotein by inducing the production of LDL and Oxidized LDL (oxLDL) and reducing the level of HDL-C at the same time. Oxidized LDL (oxLDL) not only exacerbates the inflammation but also promotes cholesterol accumulation in lysosomes, which eventually leads to cell death. On the other hand, HDL has a reverse cholesterol transport (RCT) function, anti-oxidative capacity, and anti-inflammatory properties by regulating dendritic cells' (DCs) differentiation, and reducing T cell activation and IL-12 production. However, these properties are reduced during chronic inflammation, such as psoriasis. 5 In this study our main goal is to evaluate the incidence of lipoprotein disorder in psoriasis patients attending tertiary care hospital in Bangladesh. # II. # Objective To assess the incidence of lipoprotein disorder in psoriasis patients attending tertiary care hospital in Bangladesh. # Medical Research Volume XXI Issue VI Version I ( D D D D ) K © 2021 Global Journals The Incidence of Lipoprotein Disorder in Patients with Psoriasis Attending in a Tertiary Care Hospital of Bangladesh III. # Methodology a) Type of Study This study is a case control study. # b) Place of study # g) Study Procedure Patients attending in the Dermatology Department were diagnosed case or psoriasis was included in the study. 60 patients with age matched control who were attending in the same Department with skin problem were also selected. These patients were selected after excluding the exclusion criteria, Psoriasis was diagnosed clinically attending in the CMCH. Secondary causes of Diabetes Mellitus and Hypertension were also excluded clinically. Selected patients were informed about the aims, objectives, significance and detail procedure of the study before examination. An informed written consent was taken from all the patients who was selected for the study and encouraged for voluntary participation and allowed freedom to withdraw from the study whenever they liked even after participation. All eligible subjects will be provided a structured questionnaire with direct supervision by the researcher herself to obtain socio-demographic and health related Then clinical examination was done. V. # Discussion Among the study subjects 60 (50% of the study Subjects) out of 120 patients were with Psoriasis and 60 (50% of the study subjects) out of 120 were without Psoriasis. The patients with Psoriasis were in the age group of 41-50 years. Among gender distribution 72(60% of the study subjects) were male. Group A and group B were statistically insignificant (p0.0). In our study most of the Psoriasis patients were male (72%). The mean age of the Psoriatic patients are 44 years, which is supported by one other study. 6 In our country female are less conscious about their health. They have to do many households work. Economically they depend on males. For health related problems, they go to local village doctors for treatment. So, their attendance in tertiary level hospital like CMCH may be less than male. In one large population-based study from the UK in which over 130,000 patients with psoriasis were included, showed higher incidences of Diabetes and Hypertension. Another study used the General Practice Research Database and found higher rates of Diabetes Mellitus, Hypertension, Hyperlipidemia, obesity and smoking in patients with psoriasis than in the controls subjects. [7][8] In one case control study conducted in USA in 2008 with data taken from the study of 1127 patients with Psoriasis and matched cohort of non-Psoriatic patients, Psoriatic patients were significantly more likely to develop Cardiovascular Co-Morbidities including Diabetes Hypertension, Hypercholesterolemia, compared with non-psoriasis patients. 9 In a hospital based case control study conducted in Italy, Metabolic Syndrome like Hyperglycemia, Hyperlipidemia, Hypertension was found significantly more common in Psoriatic patients than in controls (30.1% vs 20.6%, Odds ratio 1.65). 10 Another case control study conducted in Korea investigators also found a higher prevalence of metabolic syndromes (17.8%), Cardiovascular disease (4.6%), Hypertension (32.5%) and Hyperlipidemia (22.3%) in patients with Psoriasis, as compared with that of the controls. 11 Regarding diastolic blood pressure mean±SD was found 82.67±7.04 mmHg in group A and it was 78.30±9.31 mmHg in group B. It was also found significant (p<0.05). Mean±SD of fasting biood sugar was found 102.53±27.67 mg/dl and post prandial blood sugar was found 144.75 ± 49.98 mg/dl among the group A patients whereas it was 92±15.37 mg/dl and 121±41.41 mg/dl in group B. Both the distribution is statistically significant (p<0.05). Among the study subjects DM was found in 26 patients (43. 1![Figure-1: Gender distribution of the study In figure-1 shows gender distribution of the study subjects where most of the patients were male in both groups. The following figure is given below in detail:](image-2.png "Figure- 1 :") -The Incidence of Lipoprotein Disorder in Patients with Psoriasis Attending in a Tertiary Care Hospital ofBangladeshIV.ResultsNMean±SDMedianRangeSignificanceAge (years)Group A6047.789.8148.0027-65P=0.159 NSGroup B6044.9711.8647.0026-65Blood pressure was recorded by a standardSphygmomanometer in sitting position aller 30minutes rest. At least two records of blood pressureof the patient were taken on two occasions. Thenaverage blood pressure was noted. Patients wereasked to come in fasting condition for at least 8 to12 hours. Fasting blood sample was taken forfasting blood sugar and fasting lipid profile. Thenpatients were given 75gm glucose mixed in 300mlof plain water. After two hours second blood samplewas also collected for post prandial blood sugar.Blood sample was collected by same laboratorytechnologist and analysis was done in the ClinicalPathology Department of CMCH.h) Data Collection MethodAll relevant information for each individual studysubject was recorded on pre-tested data sheet. The data sheet was used for collection of information.D D D D ) KData was collected by the researcher.(i) Data Processing PlanData was processed and analyzed using computersoftware SPSS (Statistical Packages for Social SciencesVersion-19). The test statistics was used for analysis ofdata are student's t test (for comparison of datapresented in quantitative scale like blood glucose level),Chi-square test (for comparison of data presented incategorical scale like presence of DM and HTN in twogroups). For any analytical test the level of significanceis 0.05 and P-value <0.05 was considered significant.© 2021 Global Journals 1 2Study GroupsFrequencyPercentageGroupA (With Psoriasis)6050%Group B (without Psoriasis)6050%Total120100% 2Table-3: Socio Demographic status of patients.Study groupVariablesGroup A, %Group B, %X 2 Test of significanceNumber% percentNumber% percentSexMale Female40 2066.7 33.372 4853.3 46.7P= 0.136 NSAge group?30 years 31-40 years6 810.0 13.320 2123.3 21.7P=0.121 NS41-50 years2440.03823.351-60 years1830.03325.0>60 years46.786.7In table-3 shows socio demographic status of patients. Among the study subject, two third was male. There was no significant difference in sex between group A and group B. In group A most of the patients belong to 4th decade and in group B was equal distribution of age group between 30-60 years. The following table is given below in detail In table-6 shows distribution of study groups according to blood pressure. There was a significant difference in systolic blood pressure and diastolic blood pressure between group A and group B. -Table-8: Distribution of study groups according to lipid profileLipid profilesNMean±SDMediumRangeSign.Serum totalGroup A60182.5840.64188.50101-299P=0.034cholesterol (mg/dl)Group B60168.5230.27170.0080-200significantSerum HDL (mg/dl)Group A6037.976.6837.5020-62P=0.032 significantGroup B6035.734.3836.0030-42Serum LDLNMean±SDMediumRangeSign.(mg/dl)Group A60120.4729.63125.0065-185P=0.022Group B60109.5221.15110.0068-144significantNMean±SDMediumRangeSign.Serum TGGroup A60160.7040.28160.0080-240P=0.046(mg/dl)Group B60146.4337.14140.5075-210significantTable-8 shows distribution of study groups according to lipid profile. There was significant difference in serum Total Cholesterol, HDL, LDL and TG between group A and B. 1VI.of Dyslipidemia?3. ExplorationoftherelationshipbetweenHyperlipidemia and Psoriasis may unveil thediscovery of another novel treatment option forpsoriasis with most promising outcome.3) in group Aand 10 patients (16.7%) in group B.[{OR(CI)}= 3.824(1.635-R 8.942)]. p:0.051. HIN found 23(38.3%) in groupA and 8(13.3%) in group B [{OR(CI)}= 4.041 (1.629-10020)]. p<0.05). * Clinical improvement in psoriasis with treatment of associated hyperlipidemia RGhazizadeh MTosa MGhazizadeh Am. J. Med. Sci 341 2011 * Psoriasis as a human model of disease tostudy inflammatory atherogenesis CLHarrington AKDey RYunus AAJoshi NNMehta Am. J. Physiol. Heart Circ. Physiol 312 2017 * Underdiagnosis and under treatment of cardiovascular risk factors in patients with moderate to severe psoriasis ABKimball PSzapary UMrowietz KReich RGLangley YYou MCHsu NYeilding DJRader NNMehta J. Am. Acad Derm 67 2012 * Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis MAGimbrone Jr GGarcia-Cardena Circ. Res 118 2016 PubMed * MGSorci-Thomas MJThomas Microdomains Inflammation, and Atherosclerosis.Circ. Res 118 2016 PubMed * Davidsons's Principles and Practice of Medicine, 21* edition BMFrier MFisher DiabetesMellitus Nicholus AB, Nicki RC, Brian RW 2010 Churchill Livingstone Edinburg * The risk of lymphoma in patients with psoriasis JMGelfand DBShin ALNeimann XWang DJMargolis ABTroxel J Invest Dertamtol 126 2006 * Risk of Myocardial Infarction in patients with Psoriasis JMGelfand ALNeimann DBShin XWang DJMargolis ABTroxel SHGibson PerryHo Diabetes and psoriasis 2006. 1956 296 JAMA * The risk of lymphoma in patients with psoriasis JMGelfand DBShin ALNeimann XWang DJMargolis ABTroxel J Invest Dertamtol 126 2006 * Risk of Myocardial Infarction in patients with Psoriasis JMGelfand ALNeimann DBShin XWang DJMargolis ABTroxel JAMA 296 2006 * prevalence of metabolic syndrome in patients with psoriasis: a hospital-based casecontrol study SHGibson PerryHo ; Gisondi PTessari GConti APiaserco SSchianchi SPesterico A AMA Arch Derm 74 5 1956. 2007 Bed Dermatol * impact of obesity and smoking on psoriasis presentation and management MDHerron MHinckley MSHoffman JPapenfuss CBHansen KPCallis Arch Dermatol 141 2005